Early Carotid Atherosclerosis in Subjects With Periodontal Diseases
Stroke 36:1195-1200, Soder,P-O.,et al, 2005
Clinical Importance of Microbleeds in Patients Receiving IV Thrombolysis
Neurol 65:1175-1178, Kakuda,W.,et al, 2005
Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia, Meta-analysis of Randomized Placebo-Controlled Trials
JAMA 294:1934-1943,1963, Schneider,L.S.,et al, 2005
Delayed Neurotoxicity in Primary Central Nervous System Lymphoma
Arch Neurol 62:1595-1600, Omuro,A.M.P.,et al, 2005
Infliximab and Reactivation of Cerebral Toxoplasmosis
NEJM 353:1530-1531, Callegari,P.E., 2005
Hemostatic Treatment in the Early Stage of Intracerebral Hemorrhage, The Recombinant Factor VIIa Experience
Stroke 36:2321-2322, Kase,C.S., 2005
Sickle Cell Trait is a Risk Factor for Early Stroke
Arch Neurol 62:1778-1779,1781, Golomb,M.R., 2005
Sickle Cell Trait Is Not a Risk Factor for Stroke
Arch Neurol 62:1780-1781, Dowling, M.M., 2005
Guillain-Barre Syndrome
Lancet 366:1653-1666, Hughes,R.C. &Comblath,D.R., 2005
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death
NEJM 353:2034-2041, Yaggi,H.K.,et al, 2005
Oligophrenin 1 Mutations Frequently Cause X-Linked Mental Retardation with Cerebellar Hypoplasia
Neurol 65:1364-1369,1346, Zanni,G.,et al, 2005
Statins and Cognitive Functioning the Elderly
Neurol 65:1388-1394, Bernick,C.,et al, 2005
Occupation and Parkinsonism in Three Movement Disorders Clinics
Neurol 65:1430-1435, Goldman,S.M.,et al, 2005
Excessive Daytime Sleepiness and Subsequent Development of Parkinson Disease
Neurol 65:1442-1446, Abbott,R.D.,et al, 2005
Neurological and Neuromuscular Disease as a Risk Factor for Respiratory Failure in Children Hospitalized With Influenza Infection
JAMA 294:2188-2194, Keren,R.,et al, 2005
Lipid Lowering Agents Are Associated With a Slower Cognitive Decline in Alzheimers Disease
JNNP 76:1624-1629, Masse,I.,et al, 2005
Efficacy of TNF a Blockade in Cyclophosphamide Resistant Neuro-Behet Disease
JNNP 76:1733-1735, Ribi,C.,et al, 2005
Clinical and Imaging Predictors of Intracerebral Haemorrhage in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
JNNP 76:70-75, Derex,I.,et al, 2005
Migraine-Anxiety Related Dizziness (MARD): A New Disorder?
JNNP 76:1-8, Furman,J.M.,et al, 2005
Prognostic Significance of Admission Levels of Troponin I in Patients With Acute Ischaemic Stroke
JNNP 76:76-81, Di Angelantonio,E.,et al, 2005
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
NEJM 352: 777-785, 828, Mayer, S.A., et al, 2005
Risk of Ischaemic Stroke in People With Migraine: Systemic Review and Meta-analysis of Observational Studies
BMJ 330:63-65, 54, Etminan,M.,et al, 2005
Homocysteine and Stroke: Evidence on a Causal Link From Mendelian Randomisation
Lancet 365:224-232, 194, Casas, J.P., et al, 2005
Association Between Hormone Replacement Therapy and Subsequent Stroke: A Meta-analysis
BMJ 330:342-345, Bath, P.M.W. & Gray, L.J., 2005
Effects of Topiramate and Gabapentin on Cognitive Abilities in Healthy Volunteers
Neurol 64:792-798, Salinsky, M.D., et al, 2005
Timing of TIAs Preceding Stroke
Neurol 64:817-820, Rothwell, P.M. & Warlow, C.P., 2005
Atypical Antipsychotic Drugs and Risk of Ischaemic Stroke: Population Based Retrospective Cohort Study
BMJ 330:445-448, Gill,S.S., et al, 2005
Lamotrigine and the Risk of Malformations in Pregnancy
Neurol 64:955-960, 938, Cunnington, M. , et al, 2005
Neuropsychological Effects of Exposure to Anticonvulsant Medication in Utero
Neurol 64:949-954, 938, Vinten,J., et al, 2005
Recurrent Stroke Associated with Cannabis Use
JNNP 76:435-437, Mateo,I.,et al, 2005
Blood Pressure Control and Risk of Stroke
Stroke 36:725-730, Li,C.,et al, 2005
Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005
Pharmacological treatment of Neuropsychiatric Symptoms of Dementia
JAMA 293:596-608, Sink,K.M.,et al, 2005
Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation
JAMA 293:699-706, OBrien,C.L. &Gage,B.F., 2005
Maternal and Infant Characteristics Associated with Perinatal Arterial Stroke in the Infant
JAMA 293:723-729, Lee,J.,et al, 2005
Ximelagatran--Promises and Concerns
JAMA 293:736-739, Gurewich,V., 2005
Role of Cerebral Amyloid Angiopathy in Intracerebral Hemorrhage in Hypertensive Patients
Neurol 64:1233-1237, Ritter,M.A.,et al, 2005
Cellular Telephones and Risk for Brain Tumors
Neurol 64:1189-1195, Christensen,H.C.,et al, 2005
Adding Aspirin to Clopidogrel After TIA and Ischemic Stroke
Neurol 64:1117-1121, Hankey,G.J. &Eikelboom,J.W., 2005
Gadolinium Encephalopathy in a Patient with Renal Failure
Neurol 64:1276-1278, Maramattom,B.V.,et al, 2005
Neuropathy Resembling CIDP in Patients Receiving Tumor Necrosis Factor-a Blockers
Neurol 64:1468-1470, Richez,C.,et al, 2005
Reversal of Warfarin-Induced Anticoagulation with Factor VIIa Prior to rt-PA in Acute Stroke
Neurol 64:1480-1481, Talkad,A.,et al, 2005
Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005
Body Fat Distribution and Long-Term Risk of Stroke Mortality
Stroke 36:1021-1025, Tanne,D.,et al, 2005
Physical Methods for Preventing Deep Vein Thrombosis in Stroke
Stroke 36:1102-1103, Grandi,F.C.,et al, 2005
Nonarteritic Ischemic Optic Neuropathy Developing Soon After Use of Sildenafil (Viagra): A Report of Seven New Cases
J Neuroophthalmol 25:9-13, Pomeranz,H. &Bhavsar,A.R., 2005
Psychiatric Side Effects During Methysergide Treatment
JNNP 76:1037-1038, Cittadini,E. &Goadsby,P.J., 2005
Donepezil for Dementia in Parkinsons Disease: A Randomised, Double Blind, Placebo Controlled, Crossover Study
JNNP 76:934-939,903, Ravina,B.,et al, 2005
Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis
JAMA 293:2496-2500, Levin,L.I.,et al, 2005
Isolated Monoparesis Following Stroke
JNNP 76:805-807, Paciaroni,M.,et al, 2005